Search Results for: HCV

October 16, 2014October 16, 2014

Antibody Identified as Key to Fighting Hepatitis C

Hepatitis C, News

A study on the discovery of neutralizing antibodies to block the hepatitis C virus entitled, “Broadly neutralizing antibodies abrogate established hepatitis C virus infection” may offer a potential therapeutic approach to ... Read more

October 15, 2014October 15, 2014

New Hepatitis C Cure Shows Promise in Small Trial

Hepatitis C, News

Promising data on hepatitis C virus (HCV) genotype 3 therapy was released by Biotron Ltd, an Australian drug development company, showing that treatment with its lead antiviral drug, BIT225, led to ... Read more

October 10, 2014October 10, 2014

UChicago Medicine Receives CDC Grant to Address Hepatitis C

Hepatitis C, News

The prevalence of Hepatitis C infections in the U.S. is alarming at roughly 3 million infected Americans, with nearly half unaware they are infected. Chicago is home to an estimated ... Read more

October 6, 2014October 6, 2014

Experimental Hepatitis C Treatment Returns Home

Hepatitis C, News

Enanta Pharmaceuticals, a biotechnology company working on the development of small molecule drugs to treat infections, has announced that it is entering into a new licensing agreement with Novartis to recover the full rights ... Read more

October 2, 2014October 2, 2014

$1.3 Million Awarded To Study Increased Prevalence Of Hepatitis C In Young Adults

Hepatitis C, News

A $1.3 million grant was recently awarded to fund a study that will explore the increased prevalence of hepatitis C infection in young adults. Kimberly Page, a professor at the University ... Read more

September 26, 2014September 26, 2014

Genetic ‘Instruction Set’ For Antibodies Effective Treatment For Hepatitis C In Mice

Hepatitis C, News

A new study led by Princeton University researchers has determined that a “triple-punch” of antibodies both prevented hepatitis C infection and wiped out the disease after it had established itself ... Read more

September 25, 2014September 25, 2014

Gilead Files Fixed-Dose Hepatitis C Combo NDA for Japanese Market

Hepatitis C, News

Gilead Sciences, Inc. recently submitted a New Drug Application (NDA) to the Pharmaceutical and Medical Devices Agency (PMDA) in Japan for approval of an experimental combination therapy of the NS5A inhibitor ledipasvir ... Read more

September 24, 2014September 24, 2014

Scientists Board Space Station to Crystallize Hepatitis C Proteins

News

The World Health Organization has declared Hepatitis C a global health concern, and Egypt is at its epicenter, with nearly 8% of its population diagnosed with a chronic hepatitis C ... Read more

September 23, 2014September 23, 2014

Janssen Heralds NICE Ruling on Hepatitis C Drug Olysio For Patients With Genotype 1, Calls For Further Approval For Genotype 4

Hepatitis C, News

The National Institute of Health and Care Excellence (NICE) recently released the Appraisal Consultation Document (ACD) for the use of Olysio® (simeprevir), developed jointly by Janssen R&D Ireland and Medivir ... Read more